Type 2 Diabetes Trial, By Invitation NCT07674979 Sponsor: West Virginia University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT07674979
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with type 2 diabetes.
  • People whose most recent blood sugar control test (called HbA1c) showed a result above 8% within the last 6 months.
  • People who have had a clinic visit in the past 6 months.
  • People who screened positive for food insecurity based on a standard 6-question survey about household food access (confirm with trial site).
  • People who receive their care through WVU cardiometabolic, endocrinology, or primary care clinics.
  • People who are able and willing to sign a written consent form to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with end-stage kidney disease.
  • People with advanced heart failure.
  • People with severe cognitive impairment (serious difficulties with thinking, memory, or understanding).
  • People with chronic pancreatitis (long-term inflammation of the pancreas).
  • People with cancer of the pancreas.
  • People who are pregnant at the time of enrolling in the trial.
  • People who are not expected to be able to use the shopping vouchers provided in the trial (for example, due to not having access to a Walmart store).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: George Sokos, DO, FACC, West Virginia University Heart and Vascular Institute

Phone: 304-598-4850

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
West Virginia University
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Hemoglobin A1c from Baseline to 5 Months; Change in Hemoglobin A1c from Baseline to 10 Months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov